| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Shiladitya Sengupta | |
| Rania Harfouche | |||
| Deboshri Banerjee | |||
| P2860 | cites work | Incipient angiogenesis | Q73365440 |
| Significance of soluble endothelial molecule E-selectin in patients with breast cancer | Q73672131 | ||
| Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles | Q74280205 | ||
| Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis | Q77459231 | ||
| Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting | Q80062216 | ||
| Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes | Q80510046 | ||
| Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer | Q82203646 | ||
| Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle | Q24560011 | ||
| An orally delivered small-molecule formulation with antiangiogenic and anticancer activity | Q24649290 | ||
| Transparent adult zebrafish as a tool for in vivo transplantation analysis | Q24656327 | ||
| Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA | Q24671742 | ||
| Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment | Q24803543 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin | Q28239719 | ||
| Nanotechnology: intelligent design to treat complex disease | Q28246583 | ||
| Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis | Q57185896 | ||
| Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin Probe | Q58831586 | ||
| Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum | Q66986046 | ||
| PEGylation, successful approach to drug delivery | Q28278538 | ||
| Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
| Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy | Q30488702 | ||
| Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture | Q30670198 | ||
| Peptide aptamers: tools for biology and drug discovery | Q30764480 | ||
| cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo | Q30824450 | ||
| Anti-neovascular therapy using novel peptides homing to angiogenic vessels | Q30833114 | ||
| Angiogenesis: regulators and clinical applications | Q31923131 | ||
| Liposome-anchored vascular endothelial growth factor aptamers | Q32022095 | ||
| Targeted delivery of multifunctional magnetic nanoparticles | Q33294984 | ||
| Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots | Q33369698 | ||
| Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics | Q33432776 | ||
| Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo | Q33500696 | ||
| Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells | Q33535259 | ||
| Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles | Q33734413 | ||
| Imaging angiogenesis and the microenvironment | Q33811205 | ||
| Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates | Q34076231 | ||
| Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres | Q34167627 | ||
| Mathematical modelling of angiogenesis. | Q34178894 | ||
| Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model | Q34314042 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Angiogenesis modulation in cancer research: novel clinical approaches | Q34742116 | ||
| Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 | Q34981750 | ||
| Prevention of carbon nanohorn agglomeration using a conjugate composed of comb-shaped polyethylene glycol and a peptide aptamer | Q35000349 | ||
| Fundamental Concepts of the Angiogenic Process | Q35577243 | ||
| The anti-angiogenic basis of metronomic chemotherapy | Q35788112 | ||
| Dendrimers and dendritic polymers in drug delivery | Q36022312 | ||
| Antineovascular therapy, a novel antiangiogenic approach | Q36066281 | ||
| VEGF as a therapeutic target in cancer | Q36319029 | ||
| Nanotechnology-based drug delivery systems | Q36419770 | ||
| Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch | Q36576720 | ||
| Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging | Q36659683 | ||
| Viral nanoparticles as tools for intravital vascular imaging | Q36876252 | ||
| Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis | Q36913926 | ||
| Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. | Q37001800 | ||
| Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle | Q37178165 | ||
| Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy | Q37194874 | ||
| Impact of nanotechnology on drug delivery. | Q37389440 | ||
| Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. | Q37461951 | ||
| Design and development of polymer conjugates as anti-angiogenic agents | Q37584438 | ||
| Modified natural nanoparticles as contrast agents for medical imaging. | Q37629944 | ||
| The future of aptamers in medicine | Q37723116 | ||
| Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting | Q38784255 | ||
| Incorporation of polylactide-polyglycolide in a cortical defect: neoangiogenesis and blood supply in a bone chamber | Q39368045 | ||
| Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles | Q39705860 | ||
| Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer | Q39721978 | ||
| Nanoparticle-aptamer conjugates for cancer cell targeting and detection. | Q39729796 | ||
| Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism. | Q39756712 | ||
| Shape effect of carbon nanovectors on angiogenesis | Q39756922 | ||
| Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles | Q39759742 | ||
| Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis | Q39811892 | ||
| Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. | Q40161384 | ||
| Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. | Q40187384 | ||
| Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer | Q40226437 | ||
| Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice | Q40248724 | ||
| Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature | Q40388042 | ||
| Antiangiogenic properties of gold nanoparticles | Q40427876 | ||
| Targeting tumor angiogenic vasculature using polymer-RGD conjugates. | Q40470453 | ||
| Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. | Q40474868 | ||
| cRGD-functionalized polymer micelles for targeted doxorubicin delivery | Q40488864 | ||
| Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model | Q40522104 | ||
| A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles | Q40582334 | ||
| Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase | Q40809157 | ||
| Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis | Q41407593 | ||
| Antiangiogenic properties of silver nanoparticles | Q43287968 | ||
| Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels | Q44014806 | ||
| PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. | Q44068621 | ||
| Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
| Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. | Q44775111 | ||
| Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery | Q44801047 | ||
| Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis | Q45201931 | ||
| Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma | Q45952675 | ||
| Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate | Q46084536 | ||
| Nanoparticles--a new colloidal drug delivery system | Q46358383 | ||
| Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system | Q46622772 | ||
| MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. | Q46735498 | ||
| Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging | Q46789795 | ||
| Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe | Q46886934 | ||
| Aptamer biosensor for protein detection using gold nanoparticles. | Q50850856 | ||
| Signaling and regulation of endothelial cell survival by angiopoietin-2. | Q53621859 | ||
| Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. | Q55473006 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| nanotechnology | Q11468 | ||
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 3 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Vascular cell | Q27723523 |
| P1476 | title | Nanotechnology-mediated targeting of tumor angiogenesis | |
| P478 | volume | 3 |
| Q36395999 | Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery |
| Q26752141 | Advances in cancer research using gold nanoparticles mediated photothermal ablation |
| Q37929553 | Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia |
| Q47996955 | Angiogenesis inhibitors in early development for gastric cancer. |
| Q92354274 | Antiangiogenic properties of nanoparticles: a systematic review |
| Q39368839 | Combination of nanotechnology with vascular targeting agents for effective cancer therapy. |
| Q47119535 | Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics. |
| Q37731706 | Development of nanoparticle-based optical sensors for pathogenic bacterial detection. |
| Q37551472 | Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio |
| Q90397600 | Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications |
| Q28817840 | Improved in vitro angiogenic behavior on anodized titanium dioxide nanotubes |
| Q35174005 | Increased production of soluble vascular endothelial growth factors receptor-1 in CHO-cell line by using new combination of chitosan-protein lipid nanoparticles |
| Q57599815 | Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures |
| Q39678216 | Liver tumor models in transgenic zebrafish: an alternative in vivo approach to study hepatocarcinogenes |
| Q38796320 | Modifying the tumor microenvironment using nanoparticle therapeutics |
| Q38831572 | Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy |
| Q39329359 | Nanoparticles as new tools for inhibition of cancer angiogenesis |
| Q35723548 | Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation. |
| Q38136246 | Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q38120320 | Nanotechnological strategies for therapeutic targeting of tumor vasculature |
| Q59049899 | Nanotechnology in Cancer Drug Delivery and Selective Targeting |
| Q90649930 | Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension |
| Q28395895 | Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis |
| Q27024850 | Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery |
| Q92637425 | Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer |
| Q38062884 | Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers. |
| Q36316020 | Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials. |
| Q39302009 | Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics. |
| Q30455820 | Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer. |
| Q38805034 | Therapeutic application of anti-angiogenic nanomaterials in cancers |
Search more.